Clinical Trial Update: Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Rose Bengal with green light for infection reduction in Acanthamoeba keratitis and fungal keratitis has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acanthamoeba Keratitis
• Fungal Keratitis

Drugs mentioned

• Rose Bengal (rose bengal)

Snippet

Sponsor: University of California, San Francisco | Conditions: Acanthamoeba Keratitis, Fungal Keratitis | Phase 3 | Status: COMPLETED | Results posted: 2026-01-30